SCHEMBL2199397

SCHEMBL2199397

Cc1nc(C(F)(F)F)c(C(=O)Nc2ccc(F)cc2Br)s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
RXFP1 Q9HBX9 2/20 0.48
RAB9A P51151 2/20 0.48
POLB P06746 2/20 0.48
NPC1 O15118 1/20 0.48
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 2/20 0.47
GAA P10253 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
MAPT P10636 6/20 0.44
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
THRB P10828 1/20 0.41
LMNA P02545 1/20 0.41
WDR5 P61964 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4160088 0.87 GAA (0.53) MEN1KMT2ARXFP1RAB9APOLB
SCHEMBL2196885 0.85 LIPE (0.46) MEN1KMT2ARAB9APOLBKDM4E
SCHEMBL5165086 0.84 MAPT (0.53) MEN1KMT2ARXFP1RAB9APOLB
SCHEMBL2200148 0.82 MAPT (0.49) KMT2ARAB9AKDM4EALDH1A1GAA
SCHEMBL4668294 0.81 GAA (0.42) MEN1KMT2ARAB9APOLBKDM4E
SCHEMBL4147962 0.81 MAPT (0.53) MEN1KMT2ARAB9APOLBKDM4E
SCHEMBL13304546 0.80 GAA (0.42) MEN1KMT2ARAB9AKDM4EALDH1A1
SCHEMBL14564515 0.79 MAPT (0.46) MEN1KMT2ARAB9ANPC1KDM4E
SCHEMBL2202643 0.79 CHRM3 (0.44) MEN1KMT2AKDM4EALDH1A1GAA
SCHEMBL12424051 0.78 WDR5 (0.41) MEN1KMT2AKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977363-B2 Fungicides/bactericides for plant protection; exhibit a strong fortifying effect in plants; for controlling cereal diseases against Puccinia species, and diseases in viticulture and fruit and vegetable production against Botrytis, Venturia or Alternaria species; low toxicity; tolrerance BAYER CROPSCIENCE AG (DE) 2011-07-12 US disclosed
US-7977363-B2 Fungicides/bactericides for plant protection; exhibit a strong fortifying effect in plants; for controlling cereal diseases against Puccinia species, and diseases in viticulture and fruit and vegetable production against Botrytis, Venturia or Alternaria species; low toxicity; tolrerance BAYER CROPSCIENCE AG (DE) 2011-07-12 US disclosed
US-7977363-B2 Fungicides/bactericides for plant protection; exhibit a strong fortifying effect in plants; for controlling cereal diseases against Puccinia species, and diseases in viticulture and fruit and vegetable production against Botrytis, Venturia or Alternaria species; low toxicity; tolrerance BAYER CROPSCIENCE AG (DE) 2011-07-12 US disclosed
US-20080242708-A1 Biphenyl-Thiazolo-Carboxamides BAYER CROPSCIENCE AG (DE) 2008-10-02 US disclosed
US-20080242708-A1 Biphenyl-Thiazolo-Carboxamides BAYER CROPSCIENCE AG (DE) 2008-10-02 US disclosed
US-20080242708-A1 Biphenyl-Thiazolo-Carboxamides BAYER CROPSCIENCE AG (DE) 2008-10-02 US disclosed
EP-1786794-A2 BIPHENYL-THIAZOLO-CARBOXAMIDES Bayer CropScience Aktiengesellschaft (DE) 2007-05-23 EP disclosed
WO-2006024387-A2 BIPHENYL-THIAZOLO-CARBOXAMIDES BAYER CROPSCIENCE AG (DE) 2006-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242708-A1 Biphenyl-Thiazolo-Carboxamides MRPL21, CBR3, NAT1 MEN1 1611/4885KMT2A 705/4885RXFP1 580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.